Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BostonGene
Waltham, Massachusetts, United States
- Ownership
- Private
- Development stage
- Commercial
01
Overview
BostonGene provides AI-driven molecular and immune profiling solutions for clinical and research applications in precision medicine. Their technology combines flow cytometry with whole transcriptome sequencing to evaluate biomarkers, gene expression, cell states, cellular composition, and immunophenotypes[5].
- Therapeutic areas
- Oncology
- Modalities
- AI-driven molecular and immune profiling solutions
- Industry
- Molecular Diagnostics
02
Partnerships
Brigham & Women'sDana Farber Cancer InstituteJohns HopkinsMass GeneralMD Anderson Cancer Center[7]
Beyond the preview
Go deeper on BostonGene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BostonGene.